Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The identification of mycobacteria, including Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacteria (NTM), remains a critical challenge in clinical and public health settings due to their pathogenicity and increasing drug resistance. Traditional diagnostic methods, such as PCR and mass spectrometry, are limited by species detectability and prolonged culture requirements. To address these limitations, this study introduces a novel approach, named NALC-Seq, which integrates next-generation sequencing (NGS) and target capture sequencing for the direct and comprehensive identification of mycobacteria from sputum samples. A total of 54 patients were prospectively or retrospectively enrolled between April 6, 2021, and November 8, 2022, and sputum samples were subjected to next generation sequencing. The NALC-Seq methodology utilizes custom-designed RNA probes for targeted enrichment of mycobacterial DNA, coupled with species identification via the mlstverse-web system. This system integrates web, upload, head, and cloud nodes to streamline data management and analysis. Our evaluation demonstrated that NALC-Seq achieved high sensitivity (98.1%) and accuracy (83.3%) in detecting diverse mycobacterial species, including rare and drug-resistant subspecies. There were discrepancies with MGIT-Seq in nine samples. These samples exhibited low smear positivity rates, and the detection of environmental mycobacteria suggested potential contamination. Furthermore, real-time identification using the MinION device significantly reduced the turnaround time from 686 to 19 h.These findings highlight the potential of NALC-Seq and mlstverse-web as an integrated diagnostic solution for overcoming the limitations of current methods. The proposed approach offers a rapid, accurate, and comprehensive strategy for mycobacterial identification, with significant implications for clinical diagnostics and public health surveillance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12095390PMC
http://dx.doi.org/10.1007/s10142-025-01609-xDOI Listing

Publication Analysis

Top Keywords

identification mycobacteria
12
real-time identification
8
mycobacteria sputum
8
sequencing nalc-seq
8
public health
8
sputum samples
8
identification
6
mycobacteria
5
nalc-seq
5
mlstverse-web advancing
4

Similar Publications

Identification of potential alternatives for isoniazid: An in silico molecular dynamics study.

J Mol Graph Model

August 2025

Department of Biotechnology, Delhi Technological University, Delhi, 110042, India. Electronic address:

Tuberculosis (TB) remains a major global health concern that affects millions and results in several casualties and these numbers are further increased because of the drug-resistant strains of Mycobacterium tuberculosis (M. tb). Current treatments, such as Isoniazid (INH), while effective, are increasingly compromised by resistance and associated side effects, emphasizing the urgent need for new therapeutic options.

View Article and Find Full Text PDF

Exploring the role of circulating microRNAs as potential diagnostic markers in Mycobacterium paratuberculosis.

Vet Ital

September 2025

Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, India.

Extracellular vesicles (EVs) are cell-derived and play a notable role in the development of chronic diseases and can be used as biomarkers as they transport microRNAs (miRNA). Existing research has found that most miRNA functions are carried out via intercellular transmission of EVs, which can protect and sort miRNAs. Early detection of disease is crucial for controlling the spread of the disease and improving livestock prognosis.

View Article and Find Full Text PDF

Disseminated Infection With in the Setting of HIV Infection Misdiagnosed as Sarcoidosis.

Case Rep Infect Dis

August 2025

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

was first identified in a patient with HIV. Here, we describe a 40-year-old man with prolonged fever and mediastinal and abdominal lymphadenopathy, who was initially misdiagnosed with sarcoidosis. A molecular study was conducted after mycobacterium was isolated from a lymph node biopsy, leading to the identification of .

View Article and Find Full Text PDF

A 24-year-old British Indian male experienced a severe and complex course of cavitating pneumonia caused by a rare co-infection with , , and a non- species. He initially presented with symptoms of community-acquired pneumonia and was treated with antibiotics and subsequently discharged. Four days later, he re-presented with hemoptysis, hypoxia, and sepsis, requiring intensive care admission.

View Article and Find Full Text PDF

Introduction: Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.

Method: Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu.

View Article and Find Full Text PDF